Wu TC

ORCID: 0000-0003-1623-4584 · 5 papers in corpus
2023
Ovarian Combined Serous Borderline Tumor/Low-grade Serous Carcinoma and Mesonephric-like Lesion: Report of 2 Cases With New Observations.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists ·doi:10.1097/pgp.0000000000000868

Ovarian combined serous borderline tumor/low-grade serous carcinomas (SBT/LGSC) and mesonephric-like adenocarcinomas (MLA) have been previously reported and the presence of identical oncogenic somatic mutations in both components supports t…

2022
Gastrointestinal Stromal Tumors Mimicking Gynecologic Disease: Clinicopathological Analysis of 20 Cases.
Diagnostics (Basel, Switzerland) ·doi:10.3390/diagnostics12071563

Diagnosis of pelvic gastrointestinal stromal tumors (GISTs) can be challenging because of their nonspecific presentation and similarity to gynecological neoplasms. In this series, we describe the clinicopathological features of 20 GIST case…

2015
Integrative Gynecology and Women's Healthcare.
Evidence-based complementary and alternative medicine : eCAM ·doi:10.1155/2015/852615
2008
Antigen-specific immunotherapy of cervical and ovarian cancer.
Immunological reviews ·doi:10.1111/j.1600-065x.2008.00622.x

We contrast the efforts to treat ovarian cancer and cervical cancer through vaccination because of their different pathobiology. A plethora of approaches have been developed for therapeutic vaccination against cancer, many of which target d…

2008
Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis.
American journal of obstetrics and gynecology ·doi:10.1016/j.ajog.2008.01.005

The goal of ovarian cancer screening is to detect disease when confined to the ovary (stage I) and thereby prolong survival. We believe this is an elusive goal because most ovarian cancer, at its earliest recognizable stage, is probably not…